CAHCardinal Health

Health care · Drug Wholesale · NYSE

CAH and 9 peers, year by year

The 9 Health care companies closest to CAH in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
CAH Cardinal Health	FY2026	$254.2B	+14.2%	3.8%	1.0%	0.7%	1.8%	n/m	n/m
CI Cigna	FY2025	$274.9B	+11.2%	-	3.3%	2.2%	-	14.3%	0.74
CNC Centene Corporation	FY2025	$194.8B	+20.0%	7.3%	−3.9%	−3.4%	2.2%	−33.4%	0.88
ELV Elevance Health	FY2025	$199.1B	+12.5%	-	3.6%	2.8%	1.6%	12.9%	0.73
COR Cencora	FY2025	$321.3B	+9.3%	3.6%	0.8%	0.5%	1.0%	103.1%	5.16
HUM Humana	FY2025	$129.7B	+10.1%	-	2.1%	0.9%	0.3%	6.7%	0.70
JNJ Johnson & Johnson	FY2025	$94.2B	+6.0%	67.9%	-	28.5%	20.9%	32.9%	0.61
MCK McKesson	FY2026	$403.4B	+12.4%	3.6%	1.5%	1.2%	1.4%	n/m	n/m
CVS CVS Health	FY2025	$402.1B	+7.8%	-	1.2%	0.4%	1.9%	2.4%	0.86
LLY Eli Lilly	FY2025	$65.2B	+44.7%	-	-	31.7%	-	77.8%	1.54

Revenuepeer median $199.1B

Sales growthpeer median +11.2%

Gross marginpeer median 5.5%

JNJ 67.9%
CNC 7.3%
CAH 3.8%
MCK 3.6%
COR 3.6%
CI -
ELV -
HUM -
CVS -
LLY -

Operating marginpeer median 1.5%

ELV 3.6%
CI 3.3%
HUM 2.1%
MCK 1.5%
CVS 1.2%
CAH 1.0%
COR 0.8%
CNC −3.9%
JNJ -
LLY -

Net marginpeer median 1.2%

FCF marginpeer median 1.6%

JNJ 20.9%
CNC 2.2%
CVS 1.9%
CAH 1.8%
ELV 1.6%
MCK 1.4%
COR 1.0%
HUM 0.3%
CI -
LLY -

Return on equitypeer median 13.6%

Debt / equitypeer median 0.80

COR 5.16
LLY 1.54
CNC 0.88
CVS 0.86
CI 0.74
ELV 0.73
HUM 0.70
JNJ 0.61
CAH n/m
MCK n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2017 to FY2026

Revenue as reported in the 10-K.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	$130.0B	$136.8B	$145.5B	$152.9B	$162.5B	$181.3B	$205.0B	$226.8B	$222.6B	$254.2B
CI Dec	$41.8B	$48.6B	$153.6B	$160.4B	$174.1B	$180.5B	$195.3B	$247.1B	$274.9B	-
CNC Dec	$48.4B	$60.1B	$74.6B	$111.1B	$126.0B	$144.5B	$154.0B	$163.1B	$194.8B	-
ELV Dec	$90.0B	$92.1B	$104.2B	$121.9B	$138.6B	$156.6B	$171.3B	$177.0B	$199.1B	-
COR Sep	$153.1B	$167.9B	$179.6B	$189.9B	$214.0B	$238.6B	$262.2B	$294.0B	$321.3B	-
HUM Dec	$53.8B	$56.9B	$64.9B	$77.2B	$83.1B	$92.9B	$106.4B	$117.8B	$129.7B	-
JNJ Dec	$76.5B	$81.6B	$82.1B	-	$78.7B	$80.0B	$85.2B	$88.8B	$94.2B	-
MCK Mar	$198.5B	$208.4B	$214.3B	$231.1B	$238.2B	$264.0B	$276.7B	$309.0B	$359.1B	$403.4B
CVS Dec	$184.8B	$194.6B	$256.8B	$268.7B	$292.1B	$322.5B	$357.8B	$372.8B	$402.1B	-
LLY Dec	$20.0B	$21.5B	$22.3B	$24.5B	$28.3B	$28.5B	$34.1B	$45.0B	$65.2B	-
Peer median	$76.5B	$81.6B	$104.2B	$141.1B	$138.6B	$156.6B	$171.3B	$177.0B	$199.1B	-

Sales growth, FY2017 to FY2026

Revenue against the fiscal year before.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	+6.9%	+5.3%	+6.4%	+5.1%	+6.2%	+11.6%	+13.0%	+10.7%	−1.9%	+14.2%
CI Dec	+4.9%	+16.4%	+216%	+4.5%	+8.5%	+3.7%	+8.2%	+26.6%	+11.2%	-
CNC Dec	+21.4%	+23.7%	+24.7%	+47.5%	+13.7%	+14.8%	+3.4%	+3.9%	+20.0%	-
ELV Dec	+6.1%	+2.3%	+13.1%	+16.9%	+13.8%	+13.0%	+9.4%	+3.3%	+12.5%	-
COR Sep	+4.3%	+9.7%	+6.9%	+5.7%	+12.7%	+11.5%	+9.9%	+12.1%	+9.3%	-
HUM Dec	−1.1%	+5.8%	+14.0%	+18.9%	+7.7%	+11.8%	+14.5%	+10.7%	+10.1%	-
JNJ Dec	+6.3%	+6.7%	+0.6%	-	+13.6%	+1.6%	+6.5%	+4.3%	+6.0%	-
MCK Mar	+4.0%	+4.9%	+2.9%	+7.8%	+3.1%	+10.8%	+4.8%	+11.7%	+16.2%	+12.4%
CVS Dec	+4.1%	+5.3%	+32.0%	+4.6%	+8.7%	+10.4%	+10.9%	+4.2%	+7.8%	-
LLY Dec	+7.8%	+7.6%	+3.8%	+9.9%	+15.4%	+0.8%	+19.6%	+32.0%	+44.7%	-
Peer median	+4.9%	+6.7%	+13.1%	+8.9%	+12.7%	+10.8%	+9.4%	+10.7%	+11.2%	-

Gross margin, FY2017 to FY2026

Gross profit / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	5.0%	5.2%	4.7%	4.5%	4.2%	3.6%	3.4%	3.3%	3.7%	3.8%
CI Dec	-	-	-	-	-	-	-	-	-	-
CNC Dec	-	-	-	-	11.5%	11.7%	11.5%	10.5%	7.3%	-
ELV Dec	-	-	-	-	-	-	-	-	-	-
COR Sep	3.0%	2.7%	2.9%	2.7%	3.2%	3.5%	3.4%	3.4%	3.6%	-
HUM Dec	-	-	-	-	-	-	-	-	-	-
JNJ Dec	66.7%	66.8%	66.4%	-	70.3%	69.3%	68.8%	69.1%	67.9%	-
MCK Mar	5.7%	5.4%	5.5%	5.2%	5.1%	5.0%	4.5%	4.2%	3.7%	3.6%
CVS Dec	15.4%	-	-	-	-	-	-	-	-	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
Peer median	10.6%	5.4%	5.5%	-	8.3%	8.3%	8.0%	7.3%	5.5%	-

Operating margin, FY2017 to FY2026

Operating income / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	1.6%	0.1%	1.4%	−2.7%	0.3%	−0.3%	0.4%	0.5%	1.0%	1.0%
CI Dec	9.4%	8.6%	5.3%	5.1%	4.6%	4.7%	4.4%	3.8%	3.3%	-
CNC Dec	2.5%	2.4%	2.4%	2.8%	1.4%	0.9%	1.9%	1.9%	−3.9%	-
ELV Dec	4.6%	5.9%	5.8%	5.2%	5.5%	5.3%	5.0%	4.4%	3.6%	-
COR Sep	0.7%	0.9%	0.6%	−2.7%	1.1%	1.0%	0.9%	0.7%	0.8%	-
HUM Dec	7.9%	5.4%	4.9%	6.5%	3.8%	4.1%	3.8%	2.2%	2.1%	-
JNJ Dec	-	-	-	-	-	-	-	-	-	-
MCK Mar	3.6%	0.4%	0.4%	1.1%	−2.1%	0.8%	1.6%	1.3%	1.2%	1.5%
CVS Dec	5.2%	2.1%	4.7%	5.2%	4.6%	2.5%	3.8%	2.3%	1.2%	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
Peer median	4.6%	2.4%	4.7%	5.1%	3.8%	2.5%	3.8%	2.2%	1.2%	-

Net margin, FY2017 to FY2026

Net income / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	1.0%	0.2%	0.9%	−2.4%	0.4%	−0.5%	0.2%	0.4%	0.7%	0.7%
CI Dec	5.4%	5.4%	3.3%	5.3%	3.1%	3.7%	2.6%	1.4%	2.2%	-
CNC Dec	1.7%	1.5%	1.8%	1.6%	1.1%	0.8%	1.8%	2.0%	−3.4%	-
ELV Dec	4.3%	4.1%	4.6%	3.8%	4.4%	3.8%	3.5%	3.4%	2.8%	-
COR Sep	0.2%	1.0%	0.5%	−1.8%	0.7%	0.7%	0.7%	0.5%	0.5%	-
HUM Dec	4.6%	3.0%	4.2%	4.4%	3.5%	3.0%	2.3%	1.0%	0.9%	-
JNJ Dec	1.7%	18.8%	18.4%	-	26.5%	22.4%	41.3%	15.8%	28.5%	-
MCK Mar	2.6%	0.0%	0.0%	0.4%	−1.9%	0.4%	1.3%	1.0%	0.9%	1.2%
CVS Dec	3.6%	−0.3%	2.6%	2.7%	2.7%	1.3%	2.3%	1.2%	0.4%	-
LLY Dec	−1.0%	15.0%	37.3%	25.2%	19.7%	21.9%	15.4%	23.5%	31.7%	-
Peer median	2.6%	3.0%	3.3%	3.2%	3.1%	3.0%	2.3%	1.4%	0.9%	-

Free cash flow, FY2017 to FY2026

Cash from operations minus capital spending.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	$797.0M	$2.4B	$2.4B	$1.6B	$2.0B	$2.8B	$2.4B	$3.3B	$1.9B	$4.5B
CI Dec	$3.6B	$3.2B	$8.4B	-	-	-	-	-	-	-
CNC Dec	$1.1B	$559.0M	$753.0M	$4.6B	$3.3B	$5.3B	$7.3B	−$490.0M	$4.3B	-
ELV Dec	$3.4B	$2.6B	$5.0B	$9.7B	$7.3B	$7.2B	$6.8B	$4.6B	$3.2B	-
COR Sep	$1.0B	$1.1B	$2.0B	$1.8B	$2.2B	$2.2B	$3.5B	$3.0B	$3.2B	-
HUM Dec	$3.5B	$1.6B	$4.5B	$4.7B	$920.0M	$3.5B	$3.0B	$2.4B	$375.0M	-
JNJ Dec	$17.8B	$18.5B	$19.9B	-	$19.8B	$17.2B	$18.2B	$19.8B	$19.7B	-
MCK Mar	$4.3B	$3.9B	$3.6B	$4.0B	$4.1B	$4.0B	$4.8B	$3.9B	$5.5B	$5.7B
CVS Dec	$6.1B	$6.8B	$10.4B	$13.4B	$15.7B	$13.4B	$10.4B	$6.3B	$7.8B	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
Peer median	$3.6B	$2.9B	$4.8B	$4.7B	$4.1B	$5.3B	$6.8B	$3.9B	$4.3B	-

FCF margin, FY2017 to FY2026

Free cash flow / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	0.6%	1.7%	1.6%	1.0%	1.2%	1.5%	1.2%	1.4%	0.8%	1.8%
CI Dec	8.6%	6.7%	5.5%	-	-	-	-	-	-	-
CNC Dec	2.2%	0.9%	1.0%	4.2%	2.6%	3.6%	4.7%	−0.3%	2.2%	-
ELV Dec	3.8%	2.8%	4.8%	7.9%	5.2%	4.6%	3.9%	2.6%	1.6%	-
COR Sep	0.7%	0.6%	1.1%	1.0%	1.0%	0.9%	1.3%	1.0%	1.0%	-
HUM Dec	6.6%	2.7%	7.0%	6.1%	1.1%	3.7%	2.8%	2.0%	0.3%	-
JNJ Dec	23.3%	22.7%	24.3%	-	25.1%	21.5%	21.4%	22.3%	20.9%	-
MCK Mar	2.2%	1.9%	1.7%	1.7%	1.7%	1.5%	1.7%	1.3%	1.5%	1.4%
CVS Dec	3.3%	3.5%	4.0%	5.0%	5.4%	4.2%	2.9%	1.7%	1.9%	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
Peer median	3.5%	2.8%	4.4%	4.6%	2.6%	3.7%	2.9%	1.7%	1.6%	-

Return on equity, FY2017 to FY2026

Net income / shareholders' equity at the year end.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	18.9%	4.2%	21.5%	n/m	34.1%	n/m	n/m	n/m	n/m	n/m
CI Dec	16.3%	6.4%	11.3%	16.8%	11.4%	15.0%	11.2%	8.4%	14.3%	-
CNC Dec	12.1%	8.2%	10.5%	7.0%	5.0%	5.0%	10.5%	12.5%	−33.4%	-
ELV Dec	14.5%	13.1%	15.2%	13.8%	17.1%	16.3%	15.2%	14.5%	12.9%	-
COR Sep	17.7%	56.5%	29.7%	n/m	n/m	n/m	n/m	n/m	103.1%	-
HUM Dec	24.9%	16.6%	22.5%	24.5%	18.2%	18.3%	15.3%	7.4%	6.7%	-
JNJ Dec	2.2%	25.6%	25.4%	-	28.2%	23.4%	51.1%	19.7%	32.9%	-
MCK Mar	45.7%	0.7%	0.4%	17.7%	n/m	n/m	n/m	n/m	n/m	n/m
CVS Dec	17.6%	−1.0%	10.4%	10.3%	10.7%	6.0%	10.9%	6.1%	2.4%	-
LLY Dec	−1.8%	32.9%	n/m	109.8%	62.2%	58.6%	48.6%	74.2%	77.8%	-
Peer median	16.3%	13.1%	13.2%	16.8%	17.1%	16.3%	15.2%	12.5%	13.6%	-

Debt / equity, FY2017 to FY2026

Total debt / shareholders' equity at the year end.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	1.65	1.49	1.27	3.79	3.48	n/m	n/m	n/m	n/m	n/m
CI Dec	0.40	1.00	0.72	0.61	0.70	0.63	0.64	0.73	0.74	-
CNC Dec	0.70	0.63	1.10	0.65	0.71	0.76	0.70	0.71	0.88	-
ELV Dec	0.75	0.66	0.62	0.61	0.64	0.67	0.64	0.76	0.73	-
COR Sep	1.67	0.11	1.49	n/m	n/m	n/m	10.40	7.69	5.16	-
HUM Dec	0.50	0.60	0.47	0.49	0.78	0.73	0.72	0.72	0.70	-
JNJ Dec	0.60	0.55	0.47	-	0.48	0.54	0.45	0.54	0.61	-
MCK Mar	0.77	0.80	0.94	1.45	n/m	n/m	n/m	n/m	n/m	n/m
CVS Dec	0.75	1.27	1.07	0.93	0.75	0.73	0.81	0.88	0.86	-
LLY Dec	1.09	0.99	5.80	2.90	1.86	1.53	2.35	2.37	1.54	-
Peer median	0.75	0.66	0.94	0.65	0.71	0.73	0.71	0.74	0.80	-

EPS (diluted), FY2017 to FY2026

Diluted earnings per share, on today's share count after splits.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
CAH Jun	$4.03	$0.81	$4.53	−$12.61	$2.08	−$3.37	$1.26	$3.45	$6.45	$7.23
CI Dec	$8.77	$10.54	$13.44	$22.96	$15.75	$21.41	$17.39	$12.12	$22.18	-
CNC Dec	$2.34	$2.26	$3.14	$3.12	$2.28	$2.07	$4.95	$6.31	−$13.53	-
ELV Dec	$14.35	$14.19	$18.47	$17.98	$24.95	$24.28	$25.22	$25.68	$25.21	-
COR Sep	$1.64	$7.53	$4.04	−$16.65	$7.39	$8.04	$8.53	$7.53	$7.96	-
HUM Dec	$16.81	$12.16	$20.10	$25.31	$22.67	$22.08	$20.00	$9.98	$9.84	-
JNJ Dec	$0.47	$5.61	$5.63	-	$7.81	$6.73	$13.72	$5.79	$11.03	-
MCK Mar	$22.73	$0.32	$0.17	$4.95	−$28.26	$7.23	$25.03	$22.39	$25.72	$38.38
CVS Dec	$6.44	−$0.57	$5.08	$5.46	$6.02	$3.26	$6.47	$3.66	$1.39	-
LLY Dec	−$0.19	$3.13	$8.89	$6.79	$6.12	$6.90	$5.80	$11.71	$22.95	-
Peer median	$6.44	$5.61	$5.63	$6.12	$7.39	$7.23	$13.72	$9.98	$11.03	-

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out CAH and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on CAH in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CAH/export.csv") into a cell.